Trans-fatty acids aggravate obesity, insulin resistance and hepatic steatosis in C57BL/6 mice, possibly by suppressing the IRS1 dependent pathway

Molecules

Volumn 21, Issue 6, 2016, Pages

  Zhao, Xiaona ^a   Shen, Cheng ^a   Zhu, Hong ^a   Wang, Cong ^a   Liu, Xiangwei ^a   Sun, Xiaolei ^a   Han, Shasha ^a   Wang, Peng ^a   Dong, Zhen ^a   Ma, Xin ^a   Hu, Kai ^a   Sun, Aijun ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatic steatosis; Insulin resistance; Obesity; Trans fatty acid

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, MOUSE; LIPID; TRANS FATTY ACID;

ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DYSLIPIDEMIA; FATTY LIVER; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; MOUSE; OBESITY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DYSLIPIDEMIAS; FATTY LIVER; GLUCOSE TOLERANCE TEST; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPIDS; MALE; MICE; MICE, INBRED C57BL; OBESITY; SIGNAL TRANSDUCTION; TRANS FATTY ACIDS;

EID: 84976406883     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21060705     Document Type: Article

References (36)

1. Mozaffarian, D.; Katan, M.B.; Ascherio, A.; Stampfer, M.J.; Willett, W.C. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601-1613.
2. Kris-Etherton, P.M.; Lefevre, M.; Mensink, R.P.; Petersen, B.; Fleming, J.; Flickinger, B.D. Trans fatty acid intakes and food sources in the U.S. population: NHANES 1999-2002. Lipids 2012, 47, 931-940.
3. Benatar, J.R.; Stewart, R.A. The effects of changing dairy intake on trans and saturated fatty acid levels - Results from a randomized controlled study. Nutr. J. 2014, 13.
4. Dhibi, M.; Brahmi, F.; Mnari, A.; Houas, Z.; Chargui, I.; Bchir, L.; Gazzah, N.; Alsaif, M.A.; Hammami, M. The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and nonalcoholic fatty liver disease (NAFLD) in rats. Nutr. Metab. (Lond.) 2011, 8.
5. Jacome-Sosa, M.M.; Borthwick, F.; Mangat, R.; Uwiera, R.; Reaney, M.J.; Shen, J.; Quiroga, A.D.; Jacobs, R.L.; Lehner, R.; Proctor, S.D. Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. J. Nutr. Biochem. 2014, 25, 692-701.
6. Motard-Belanger, A.; Charest, A.; Grenier, G.; Paquin, P.; Chouinard, Y.; Lemieux, S.; Couture, P.; Lamarche, B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr. 2008, 87, 593-599.
7. Rector, R.S.; Thyfault, J.P.; Uptergrove, G.M.; Morris, E.M.; Naples, S.P.; Borengasser, S.J.; Mikus, C.R.; Laye, M.J.; Laughlin, M.H.; Booth, F.W.; et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 2010, 52, 727-736.
8. Monetti, M.; Levin, M.C.; Watt, M.J.; Sajan, M.P.; Marmor, S.; Hubbard, B.K.; Stevens, R.D.; Bain, J.R.; Newgard, C.B.; Farese, R.S.; et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007, 6, 69-78.
9. Hanyu, O.; Miida, T.; Obayashi, K.; Ikarashi, T.; Soda, S.; Kaneko, S.; Hirayama, S.; Suzuki, K.; Nakamura, Y.; Yamatani, K.; et al. Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity. Atherosclerosis 2004, 174, 385-390.
10. Kershaw, E.E.; Hamm, J.K.; Verhagen, L.A.; Peroni, O.; Katic, M.; Flier, J.S. Adipose triglyceride lipase: Function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006, 55, 148-157.
11. Joseph, R.; Poschmann, J.; Sukarieh, R.; Too, P.G.; Julien, S.G.; Xu, F.; Teh, A.L.; Holbrook, J.D.; Ng, K.L.; Chong, Y.S.; et al. ACSL1 is associated with fetal programming of insulin sensitivity and cellular lipid content. Mol. Endocrinol. 2015, 29, 909-920.
12. Ranganathan, G.; Unal, R.; Pokrovskaya, I.; Yao-Borengasser, A.; Phanavanh, B.; Lecka-Czernik, B.; Rasouli, N.; Kern, P.A. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: Effects of obesity, insulin resistance, and TZD treatment. J. Lipid Res. 2006, 47, 2444-2450.
13. Glenn, D.J.; Wang, F.; Nishimoto, M.; Cruz, M.C.; Uchida, Y.; Holleran, W.M.; Zhang, Y.; Yeghiazarians, Y.; Gardner, D.G. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension 2011, 57, 216-222.
14. Wang, H.; Knaub, L.A.; Jensen, D.R.; Young, J.D.; Hong, E.G.; Ko, H.J.; Coates, A.M.; Goldberg, I.J.; de la Houssaye, B.A.; Janssen, R.C.; et al. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 2009, 58, 116-124.
15. Ozcan, U.; Cao, Q.; Yilmaz, E.; Lee, A.H.; Iwakoshi, N.N.; Ozdelen, E.; Tuncman, G.; Gorgun, C.; Glimcher, L.H.; Hotamisligil, G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306, 457-461.
16. Groop, L.C.; Bonadonna, R.C.; Simonson, D.C.; Petrides, A.S.; Shank, M.; DeFronzo, R.A. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am. J. Physiol. 1992, 263, E79-E84.
17. Kahn, S.E.; Hull, R.L.; Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444, 840-846.
18. Leclercq, I.A.; Da, S.M.A.; Schroyen, B.; Van Hul, N.; Geerts, A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J. Hepatol. 2007, 47, 142-156.
19. Hoehn, K.L.; Hohnen-Behrens, C.; Cederberg, A.; Wu, L.E.; Turner, N.; Yuasa, T.; Ebina, Y.; James, D.E. IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 2008, 7, 421-433.
20. Pereira, S.; Breen, D.M.; Naassan, A.E.; Wang, P.Y.; Uchino, H.; Fantus, I.G.; Carpentier, A.C.; Gutierrez-Juarez, R.; Brindley, D.N.; Lam, T.K.; et al. In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism 2015, 64, 315-322.
21. Boden, G.; She, P.; Mozzoli, M.; Cheung, P.; Gumireddy, K.; Reddy, P.; Xiang, X.; Luo, Z.; Ruderman, N. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54, 3458-3465.
22. McCurdy, C.E.; Bishop, J.M.; Williams, S.M.; Grayson, B.E.; Smith, M.S.; Friedman, J.E.; Grove, K.L. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J. Clin. Investig. 2009, 119, 323-335.
23. Liang, C.; DeCourcy, K.; Prater, M.R. High-saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice. Metabolism 2010, 59, 943-950.
24. Fan, S.; Zhang, Y.; Sun, Q.; Yu, L.; Li, M.; Zheng, B.; Wu, X.; Yang, B.; Li, Y.; Huang, C. Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice. J. Nutr. Biochem. 2014, 25, 702-709.
25. Asai, A.; Chou, P.M.; Bu, H.F.; Wang, X.; Rao, M.S.; Jiang, A.; DiDonato, C.J.; Tan, X.D. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306, G496-G504.
26. Musso, G.; Cassader, M.; De Michieli, F.; Rosina, F.; Orlandi, F.; Gambino, R. Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Hepatology 2012, 56, 933-942.
27. Mullaney, B.C.; Blind, R.D.; Lemieux, G.A.; Perez, C.L.; Elle, I.C.; Faergeman, N.J.; van Gilst, M.R.; Ingraham, H.A.; Ashrafi, K. Regulation of C. elegans fat uptake and storage by acyl-CoA synthase-3 is dependent on NR5A family nuclear hormone receptor nhr-25. Cell Metab. 2010, 12, 398-410.
28. Lee, Y.; Naseem, R.H.; Duplomb, L.; Park, B.H.; Garry, D.J.; Richardson, J.A.; Schaffer, J.E.; Unger, R.H. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc. Natl. Acad. Sci. USA 2004, 101, 13624-13629.
29. Morak, M.; Schmidinger, H.; Riesenhuber, G.; Rechberger, G.N.; Kollroser, M.; Haemmerle, G.; Zechner, R.; Kronenberg, F.; Hermetter, A. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues. Mol. Cell. Proteom. 2012, 11, 1777-1789.
30. Zhang, Y.; Ren, J. Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy. Hypertension 2011, 57, 148-150.
31. Mong, M.; Hsia, T.; Yin, M. Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice. J. Food Sci. 2013, 78, 1621-1628.
32. -/- Mice. J. Cardiovasc. Pharmacol. 2015, 65, 620-627.
33. Mauer, J.; Chaurasia, B.; Goldau, J.; Vogt, M.C.; Ruud, J.; Nguyen, K.D.; Theurich, S.; Hausen, A.C.; Schmitz, J.; Bronneke, H.S.; et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 2014, 15, 423-430.
34. Xu, X.; Hueckstaedt, L.K.; Ren, J. Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: Role of autophagy. J. Hepatol. 2013, 59, 308-317.
35. Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O'Dea, K.; Desmond, P.V.; Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J. Hepatol. 2013, 59, 138-143.
36. Shen, C.; Wang, C.; Fan, F.; Yang, Z.; Cao, Q.; Liu, X.; Sun, X.; Zhao, X.; Wang, P.; Ma, X.; et al. Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Biochim. Biophys. Acta 2015, 1852, 310-318.